ASR
Asra Minerals Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
8
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Asra Minerals Ltd. engages in the development and exploration of mineral properties. The company is headquartered in Perth, Western Australia. The firm is focused on developing gold and rare earth elements (REE) and critical minerals projects in Western Australia. The firm's Mt Stirling Project is located near the mining town of Leonora, approximately 240 kilometers (km) north of Kalgoorlie in Western Australia and hosts approximately 10 gold prospects, as well as an inventory of clean heavy rare earth elements and critical minerals. Its Mt Stirling deposit contains five critical REEs: Dysprosium (Dy), Terbium (Tb), Europium (Eu), Neodymium (Nd) and Yttrium (Y). Its Kookynie West project is located approximately 40 km south of its Mt Stirling Gold and REE Project. The firm owns the approximately 172,662-hectare Tarmoola Pastoral Station, which underlies the Company’s gold and REE deposits and infrastructure.
📈 Performance
Price History
+368.75%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ASR
8
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ASR
495 days
ASR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
13%
50k - 100k
33%
Less than 50k
53%
👶 Age of investors
18 - 25
25%
26 - 34
13%
35 - 90
63%
🙋 Legal gender of investors
Female
63%
Male
38%
Pearlers who invest in ASR also invest in...
Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 446 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.
📊 Share price
$4.67 AUD
NULL RESOURCES
Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for a variety of cancers, atherosclerosis and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. The company produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. The company is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).
📊 Share price
$0.01 AUD
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The company is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.
📊 Share price
$0.05 AUD
Want more shares? Try these...
Advanced Share Registry Ltd. engages in the provision of maintenance, investor relations, and associated services to listed and unlisted clients on a state and national basis. The company is headquartered in Nedlands, Western Australia and currently employs 21 full-time employees. The company went IPO on 2008-06-10. The firm operates through two business segments, share registrar services and management of investment property. The company offers a range of services, including registry management, meeting management, employee plan solutions, and printing and mailing solution. The company also offers an online platform for investors to view and update all shareholder details relating to their investments. The firm partners with investor and media relations service providers and offers its clients a range of market intelligence tools, including register analysis reports with detailed share ownership data, customer relationship management (CRM) platform, and contacts database. In addition, it also provides services in a range of corporate actions and capital raisings, such as initial public offerings (IPOs), share buy backs, rights issues, share purchase plans and more.
📊 Share price
$0.14 AUD
Aspermont Ltd. operates as a media company, which engages in the production of business-to-business information services delivered through print, conferencing, and online media channels. The company is headquartered in Perth, Western Australia. The company went IPO on 2000-04-27. The firm is engaged in providing market-specific content across the resources sectors through a combination of print, digital media channels and face-to-face networking channels. The firm's segments include XaaS, Services and Data. The firm's products and services include subscription, advertising, content marketing and sponsorship and online publications, as well as running events and data services, including virtual events and lead generation across a number of trade sectors, including the mining, agriculture, energy and resources sectors. The firm's publications, research and events provide industry news and information through the brands, such as Mining Journal, Mining Magazine, GeoDrilling International, Australia's Mining Monthly, RESOURCESTOCKS, PNGReport, Farming Ahead, Energy News Bulletin, MiningNews.net, Noticias de Mineracao Brasil and International Coal News.
📊 Share price
$0.02 AUD
Australian Silica Quartz Group Ltd. engages in the acquisition, exploration, and development of bauxite, alumina, and aluminum ores. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-10-22. The firm is focused on its high-grade silica sand and hard rock quartz projects. The company is engaged in the exploration and development of silica sand projects in Western Australia, hard rock silica quartz projects in Western Australia and Far North Queensland, Darling Range bauxite projects held within the HD Mining Joint Venture and exploration of the South Stirling Project in Western Australia for nickel/copper sulfide deposits. The Koolyanobbing Metals project is located approximately 40 kilometers (km) northeast of southern cross and surrounds the Koolyanobbing Iron Ore Mine. The Gingin Silica Sand project consists of one application exploration license located 20 km north of Perth, the Albany Silica Sand project consists of four granted exploration licenses and one application exploration license within 10-80 km of the Port of Albany. The company also includes the Albany White Hill Silica Sand project.
📊 Share price